Profile data is unavailable for this security.
About the company
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.
- Revenue in USD (TTM)0.00
- Net income in USD-9.33m
- Incorporated2003
- Employees6.00
- LocationInVivo Therapeutics Holdings CorpBuilding 1400 East 4Th FloorOne Kendall SquareCAMBRIDGE 02139United StatesUSA
- Phone+1 (617) 863-5524
- Websitehttps://www.invivotherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sientra Inc | 90.30m | -59.33m | 837.04k | 304.00 | -- | -- | -- | 0.0093 | -5.45 | -5.43 | 8.10 | -2.82 | 0.5905 | 1.15 | 2.82 | 297,036.20 | -38.80 | -45.08 | -163.51 | -76.22 | 42.11 | 55.37 | -65.71 | -103.79 | 0.3106 | -14.23 | 2.20 | -- | 12.23 | 19.90 | -17.26 | -- | 14.01 | -- |
| Grapefruit USA Inc | 34.85k | -4.37m | 996.04k | 9.00 | -- | -- | -- | 28.58 | -0.008 | -0.008 | 0.00006 | -0.0101 | 0.0121 | 1.31 | 0.2259 | 3,872.22 | -151.85 | -268.93 | -- | -- | -1,304.65 | -10.09 | -12,531.68 | -408.87 | 0.0388 | -1.50 | -- | -- | -83.96 | 77.87 | -35.68 | -- | -- | -- |
| SETO Holdings Inc | 4.96m | -652.00k | 1.00m | 18.00 | -- | 0.0911 | -- | 0.2024 | -0.056 | -0.056 | 0.3994 | 0.134 | 1.57 | 2.65 | 8.51 | -- | -20.70 | 3.84 | -29.07 | 5.95 | 52.83 | 52.44 | -13.15 | 3.92 | 0.9921 | 1.24 | 0.304 | 0.00 | 19.01 | 5.44 | -61.23 | -- | -- | -- |
| Prosomnus Inc | 25.61m | -15.02m | 1.04m | 129.00 | -- | -- | -- | 0.0406 | -0.942 | -0.942 | 1.52 | -1.33 | 1.20 | 11.86 | 8.85 | 198,496.50 | -70.44 | -- | -164.95 | -- | 52.38 | -- | -58.65 | -- | 1.38 | -3.15 | 2.57 | -- | 37.79 | -- | -19.54 | -- | -- | -- |
| Hawkeye Systems Inc | 0.00 | -804.18k | 1.04m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
| Aethlon Medical, Inc. | 574.25k | -12.26m | 1.05m | 15.00 | -- | 0.1365 | -- | 1.83 | -5.03 | -5.03 | 0.2362 | 2.93 | 0.0369 | -- | -- | 38,283.33 | -78.62 | -75.30 | -92.02 | -84.98 | -- | -- | -2,133.17 | -1,783.78 | -- | -- | 0.00 | -- | 95.21 | 30.86 | -15.55 | -- | 106.99 | -- |
| Remedent Inc | 1.13m | -259.38k | 1.10m | 16.00 | -- | 0.2324 | -- | 0.9743 | -0.013 | -0.013 | 0.0565 | 0.2367 | 0.1474 | 3.45 | 2.69 | -- | -3.24 | 7.35 | -5.20 | 12.93 | 65.38 | 64.60 | -21.97 | 21.20 | 0.2033 | -0.772 | 0.00 | -- | -33.63 | -21.70 | -140.31 | -- | -- | -- |
| Invivo Therapeutics Holdings Corp | 0.00 | -9.33m | 1.15m | 6.00 | -- | 0.1288 | -- | -- | -3.53 | -3.53 | 0.00 | 2.87 | 0.00 | -- | -- | 0.00 | -81.32 | -73.69 | -94.35 | -85.63 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.01 | -- | 19.74 | -- |
| SPO Global Inc | 838.00k | -540.00k | 1.27m | 2.00 | -- | -- | -- | 1.51 | -85.99 | -85.99 | 131.76 | -476.56 | 1.76 | -- | -- | -- | -113.56 | -305.39 | -- | -- | 31.15 | 27.31 | -64.44 | -384.85 | -- | -1.45 | -- | -- | -17.09 | -15.13 | 13.03 | -- | -- | -- |
| Nemaura Medical Inc | 0.00 | -10.65m | 1.30m | 36.00 | -- | -- | -- | -- | -0.3787 | -0.3787 | 0.00 | -0.6169 | 0.00 | 0.00 | -- | 0.00 | -117.49 | -58.18 | -- | -131.96 | -- | -- | -- | -7,384.83 | 0.0305 | -1.47 | 10.81 | -- | -84.71 | -- | -1.85 | -- | 64.14 | -- |
| Acutus Medical Inc | 7.16m | -11.92m | 1.34m | 233.00 | -- | -- | -- | 0.1867 | -0.4097 | -0.417 | 0.2467 | -0.0308 | 0.0765 | 1.17 | 0.4417 | 30,746.78 | -12.72 | -46.76 | -16.05 | -56.88 | -43.79 | -89.12 | -166.40 | -773.49 | 2.22 | -6.78 | 1.03 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| Escalon Medical Corp | 12.38m | 450.50k | 1.38m | 38.00 | 7.18 | 1.47 | 2.78 | 0.1114 | 0.0259 | 0.0259 | 1.18 | 0.1951 | 2.65 | 4.04 | 8.01 | 325,898.70 | 14.68 | -1.76 | 35.71 | -3.67 | 46.26 | 44.57 | 5.54 | -0.9114 | 1.09 | 31.90 | 0.1504 | -- | 13.80 | 1.33 | 760.89 | -17.06 | -19.85 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Dec 2023 | 163.10k | 5.25% |
| Tower Research Capital LLCas of 31 Dec 2023 | 8.40k | 0.27% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 263.00 | 0.01% |
| VIMA LLCas of 31 Dec 2023 | 2.00 | 0.00% |
| Sugarloaf Wealth Management LLCas of 31 Mar 2024 | 1.00 | 0.00% |
| UBS Financial Services, Inc.as of 31 Dec 2023 | 1.00 | 0.00% |
| Allworth Financial LPas of 31 Mar 2024 | 0.00 | 0.00% |
| Milestone Investment Advisors LLCas of 31 Dec 2023 | 0.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 0.00 | 0.00% |
| Indiana Trust & Investment Management Co.as of 31 Mar 2024 | 0.00 | 0.00% |
